Working… Menu

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00116610
Recruitment Status : Completed
First Posted : June 30, 2005
Last Update Posted : January 21, 2009
Information provided by:
Poniard Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2007
Actual Study Completion Date : March 2008